Review: taking Warfarin sodium and Lactulose together


Summary

Drug interactions are reported among people who take Warfarin sodium and Lactulose together. This review analyzes the effectiveness and drug interactions between Warfarin sodium and Lactulose. It is created by eHealthMe based on reports of 1,163 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Warfarin sodium and Lactulose >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Warfarin Sodium

Warfarin sodium has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Warfarin sodium 50,491 users)

Lactulose

Lactulose has active ingredients of lactulose. It is often used in constipation. (latest outcomes from Lactulose 15,692 users)

On Aug, 28, 2016

1,163 people who take Warfarin Sodium, Lactulose are studied.


Number of reports submitted per year:

Warfarin sodium and Lactulose drug interactions.

Drug effectiveness over time:

Warfarin Sodium:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 2 people)
  • not specified: 0.0% - (0 of 0 people)
Lactulose:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Warfarin Sodium:
  • female: 33.0% - (1 of 3 people)
  • male: 0.0% - (0 of 1 people)
Lactulose:
  • female: 33.0% - (1 of 3 people)
  • male: 50.0% - (1 of 2 people)

Drug effectiveness by age:

Warfarin Sodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 50.0% - (1 of 2 people)
Lactulose:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 66.0% - (2 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • gastric perforation
  • nausea
  • peripheral ischaemia
  • deep vein thrombosis
  • international normalised ratio increased
  • dehydration
  • anaemia
  • arthralgia
  • ascites
  • fall
1 - 6 months:
  • proteinuria
  • cardiac failure
  • myocardial ischaemia
  • calciphylaxis
  • international normalised ratio increased
  • multiple myeloma
  • nausea
  • retroperitoneal haemorrhage
  • cholangitis
  • haematoma
6 - 12 months:
  • age-related macular degeneration
  • bleeding time prolonged
  • blood bilirubin increased
  • cerebral haemorrhage
  • cerebrovascular accident
  • cholelithiasis
  • choroidal neovascularisation
  • coma
  • depression
  • dyspnoea exacerbated
1 - 2 years:
  • anal fissure
  • peripheral ischaemia
  • accidental overdose
  • age-related macular degeneration
  • arteriovenous malformation
  • bladder disorder
  • bleeding time prolonged
  • cerebral haemorrhage
  • cerebrovascular accident
  • choroidal neovascularisation
2 - 5 years:
  • abdominal pain
  • acute respiratory distress syndrome
  • anxiety and stress
  • asthenia
  • chest pain
  • chest pressure sensation
  • death
  • dehydration
  • depression
  • diarrhoea
5 - 10 years:
  • suicide attempt
  • aggression
  • anxiety
  • depression
  • intentional overdose
  • loss of consciousness
10+ years:
  • abdominal pain
  • anxiety and stress
  • chest pain
  • chest pressure sensation
  • depression
not specified:
  • dyspnoea
  • pain
  • cardiac failure congestive
  • anxiety
  • nausea
  • anaemia
  • renal failure acute
  • pneumonia
  • international normalised ratio increased
  • atrial fibrillation

Most common drug interactions by gender *:

female:
  • anaemia
  • nausea
  • international normalised ratio increased
  • pain
  • chest pain
  • dyspnoea
  • atrial fibrillation
  • fatigue
  • back pain
  • anxiety
male:
  • dyspnoea
  • renal failure acute
  • pain
  • pneumonia
  • cardiac failure congestive
  • anxiety
  • deep vein thrombosis
  • hypotension
  • fall
  • nausea

Most common drug interactions by age *:

10-19:
  • prothrombin level decreased
20-29:
  • cardiac failure congestive
  • sinusitis
  • back pain
  • bronchitis
  • nausea
  • influenza like illness
  • insomnia
  • intracardiac thrombus
  • tuberculin test positive
  • urinary tract infection
30-39:
  • abdominal pain
  • anxiety
  • emotional distress
  • insomnia
  • pain
  • cellulitis
  • depression
  • fibrosis
  • gait disturbance
  • haemoglobin decreased
40-49:
  • dyspnoea
  • fatigue
  • abdominal pain
  • anaemia
  • injury
  • neuropathy peripheral
  • bone disorder
  • pain
  • urinary tract infection
  • deep vein thrombosis
50-59:
  • hepatic failure
  • nausea
  • cholelithiasis
  • headache
  • chest pain
  • fatigue
  • constipation
  • international normalised ratio increased
  • pain
  • pneumonia
60+:
  • dyspnoea
  • pain
  • cardiac failure congestive
  • international normalised ratio increased
  • anaemia
  • atrial fibrillation
  • hypotension
  • renal failure acute
  • anxiety
  • nausea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Warfarin sodium and Lactulose?

Can you answer these questions?

More questions for: Warfarin sodium, Lactulose

You may be interested in these reviews

More reviews for: Warfarin sodium, Lactulose

On eHealthMe, Warfarin sodium (warfarin sodium) is often used to treat atrial fibrillation/flutter. Lactulose (lactulose) is often used to treat constipation. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.